{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,9]],"date-time":"2023-12-09T00:19:27Z","timestamp":1702081167511},"reference-count":114,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2023,4,3]]},"DOI":"10.1080\/17425247.2023.2189697","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T05:02:05Z","timestamp":1678338125000},"page":"489-506","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Lessons learned from the SARS-CoV-2 pandemic; from nucleic acid nanomedicines, to clinical trials, herd immunity, and the vaccination divide"],"prefix":"10.1080","volume":"20","author":[{"given":"Hiba","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishwarya","family":"Ganesh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lara","family":"Milane","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansoor","family":"Amiji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Northeastern University, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"cit0001","unstructured":"Organization WH. WHO: COVID-19 vaccine tracker and landscape 2022. Accessed Nov 23 2022. Available from: https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants"},{"key":"cit0002","unstructured":"CEPI. A world in which epidemics and pandemics are no longer a threat to humanity 2022. cited Nov 23 2022. Available from: https:\/\/cepi.net\/about\/whyweexist\/"},{"key":"cit0003","unstructured":"Office USGA Operation warp speed: accelerated COVID-19 vaccine development status and efforts to address manufacturing challenges 2021. Accessed Nov 23 2022. Available from: https:\/\/www.gao.gov\/products\/gao-21-319"},{"key":"cit0004","unstructured":"Trial WS WHO COVID-19 solidarity therapeutics trial 2022. Accessed Nov 23 2022. Available from: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/global-research-on-novel-coronavirus-2019-ncov\/solidarity-clinical-trial-for-covid-19-treatments"},{"key":"cit0005","unstructured":"Administration USFa D FDA approves first COVID-19 vaccine 2021. Accessed Nov 23 2022. Available from: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-covid-19-vaccine"},{"key":"cit0006","unstructured":"University&Medicine JH. John Hopkins University & Medicine, coronavirus resource center 2022. Accessed Nov 23 2022. Available from: https:\/\/coronavirus.jhu.edu\/vaccines\/international"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2798-3"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.13.093195"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.75.1.280"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13195002"},{"key":"cit0011","first-page":"22","volume":"23","author":"Feynman R","year":"1960","journal-title":"Eng Sci"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(64)80115-7"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00911-y"},{"key":"cit0014","volume-title":"China releases genetic data on new coronavirus, now deadly","author":"Schnirring L","year":"2020"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020198"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.05.021"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1186\/1556-276X-8-102"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.06.052"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.4161\/hv.26796"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S198353"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1088\/2632-959X\/abeb4b"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020147"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.200"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.243"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.017"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9020097"},{"key":"cit0028","unstructured":"Vgcvt T. Covid 19 vaccine tracker 2022. cited Nov 23 2022. Available from: https:\/\/covid19.trackvaccines.org\/"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.04.001"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.12.006"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2016.1124762"},{"key":"cit0032","first-page":"113","volume":"351","author":"Romani N","year":"2012","journal-title":"Curr Top Microbiol Immunol"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100689"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-02385-x"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1007\/s11051-020-05010-6"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-021-02383-z"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106845118"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00292-w"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.2007.B0153"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00163-y"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2017.06.002"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107659"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041451"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2005191118"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1186\/s13099-022-00495-z"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2022.113325"},{"key":"cit0047","author":"Kupferschmidt K","year":"2022","journal-title":"Science"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00140-6"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00216-4"},{"key":"cit0050","unstructured":"CEPI. COVAX: cEPI\u2019s response to COVID-19 2022. Accessed Nov 23 2022. Available from: https:\/\/cepi.net\/covax\/"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080886"},{"key":"cit0052","unstructured":"Pfizer. Pfizer and BioNTech announce data from preclinical studies of mRNA-based vaccine candidate against COVID-19 2020. Accessed Nov 23 2022. Available from: https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-announce-data-preclinical-studies-mrna"},{"key":"cit0053","unstructured":"NIo H. Study to describe the safety, tolerability, immunogenicity, and efficacy of RNA vaccine candidates against COVID-19 in healthy individuals 2022. Accessed Nov 23 2022. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04368728"},{"key":"cit0054","unstructured":"USFaD A. Emergency use authorization for vaccines explained 2020. Accessed Nov 23 2022. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/emergency-use-authorization-vaccines-explained"},{"key":"cit0055","unstructured":"FDA: BLA Approval [Internet]. 2021. Accessed Nov 23 2022. Available from: https:\/\/www.fda.gov\/media\/151710\/download"},{"key":"cit0056","unstructured":"FDA. Comirnaty and Pfizer-BioNTech COVID-19 vaccine 2022. Accessed Nov 23 2022. Available from: https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/comirnaty-and-pfizer-biontech-covid-19-vaccine"},{"key":"cit0057","unstructured":"Moderna. Moderna receives full U.S. Fda approval for Covid-19 vaccine Spikevax 2022. Accessed Nov 23 2022. Available from: https:\/\/investors.modernatx.com\/news\/news-details\/2022\/Moderna-Receives-Full-U.S.FDA-Approval-for-COVID-19-Vaccine-Spikevax\/default.aspx"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-03076-0"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01446-y"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01699-1"},{"key":"cit0062","unstructured":"Organization WH. WHO-convened global study of origins of SARS-CoV-2: China part joint WHO-China study 14 January-10 February 2021 joint report. 2021."},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2012-7"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2313-x"},{"key":"cit0065","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020488"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1785"},{"key":"cit0067","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2020.141711"},{"key":"cit0068","volume-title":"Transmission of SARS-CoV-2: implications for infection prevention precautions","author":"Organization WH","year":"2020"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38808-z"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.4161\/viru.27172"},{"key":"cit0071","unstructured":"Inhaled Product Characterization [Internet]. 2011. Accessed Nov 23 2022. Available from: https:\/\/www.pharmtech.com\/view\/inhaled-product-characterization."},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25156-8"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821001084"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1038\/nature12711"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00653-w"},{"issue":"9","key":"cit0077","first-page":"3409","volume":"39","author":"Boopathi S","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"cit0078","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0060226"},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd3629"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1016\/j.tim.2020.05.009"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(06)66005-3"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2574"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73162-5"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.034"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2020.05.003"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111752"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01418-7"},{"key":"cit0088","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.13707"},{"key":"cit0089","doi-asserted-by":"publisher","DOI":"10.1016\/S2666-5247(20)30003-3"},{"issue":"2","key":"cit0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1753-6405.1992.tb00056.x","volume":"16","author":"Becker NG","year":"1992","journal-title":"Aus J Public Health"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2020.8516"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1865046"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103344"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.09.005"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.614650"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2104847118"},{"key":"cit0097","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.619738"},{"key":"cit0098","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-102119-073855"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021756"},{"key":"cit0100","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2021.05.076"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10369"},{"key":"cit0102","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.13443"},{"key":"cit0103","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110737"},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729251"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102685"},{"key":"cit0106","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2104882"},{"key":"cit0107","unstructured":"Agency EM AstraZeneca\u2019s COVID-19 vaccine: benefits and risks in context 2021. Accessed Nov 23 2022. Available from: https:\/\/www.ema.europa.eu\/en\/news\/astrazenecas-covid-19-vaccine-benefits-risks-context"},{"key":"cit0108","first-page":"1","volume":"2021","author":"Hekmat AS","year":"2021","journal-title":"Bio Med Res Int"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1955101"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n699"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1612973"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000137119.28893.0b"},{"key":"cit0113","unstructured":"CDC. CDC: waning 2-Dose and 3-dose effectiveness of mRNA vaccines against COVID-19\u2013associated Emergency department and urgent care encounters and hospitalizations among adults during periods of delta and omicron variant predominance 2022. Accessed Nov 23 2022. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7107e2.htm"},{"key":"cit0114","volume-title":"Coronavirus (COVID-19) update: fDA authorizes moderna, Pfizer-BioNTech bivalent COVID-19 vaccines for use as a booster dose","author":"FDA","year":"2022"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2023.2189697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T15:24:34Z","timestamp":1702049074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2023.2189697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4,3]]}},"alternative-id":["10.1080\/17425247.2023.2189697"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2023.2189697","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}